| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.7M | — | — |
| Cost of Revenue | $5.6M | — | — |
| Gross Profit | $106K | — | — |
| R&D Expense | $14.2M | — | +743.6% |
| SG&A Expense | $21.2M | — | +201.3% |
| Operating Income | -$36.7M | — | -320.7% |
| Interest Expense | $35K | — | -35.2% |
| Pre-tax Income | -$68.6M | — | -232.8% |
| Income Tax | -$577K | — | — |
| Net Income | -$67.0M | — | -229.2% |
| EPS (Basic) | -$0.34 | — | -145.3% |
| EPS (Diluted) | -$0.34 | — | -158.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.75B | +386.1% | +7392.8% |
| Inventory | $28.4M | +53.4% | — |
| Current Assets | $1.79B | +364.6% | +6845.1% |
| Total Assets | $2.13B | +207.2% | +2669.8% |
| Current Liabilities | $49.3M | +30.1% | +572.8% |
| Total Liabilities | $246.3M | +28.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.5M | — | -78.7% |
| Investing Cash Flow | -$38.6M | — | -1166.9% |
| Financing Cash Flow | $1.45B | — | +7147.0% |
| +153.0% |
| Stockholders' Equity | $1.88B | +280.1% | +3668.4% |